245 related articles for article (PubMed ID: 23184315)
1. Deep brain stimulation of the subthalamic nucleus, but not dopaminergic medication, improves proactive inhibitory control of movement initiation in Parkinson's disease.
Favre E; Ballanger B; Thobois S; Broussolle E; Boulinguez P
Neurotherapeutics; 2013 Jan; 10(1):154-67. PubMed ID: 23184315
[TBL] [Abstract][Full Text] [Related]
2. Interaction of noradrenergic pharmacological manipulation and subthalamic stimulation on movement initiation control in Parkinson's disease.
Albares M; Thobois S; Favre E; Broussolle E; Polo G; Domenech P; Boulinguez P; Ballanger B
Brain Stimul; 2015; 8(1):27-35. PubMed ID: 25284704
[TBL] [Abstract][Full Text] [Related]
3. Focused stimulation of dorsal subthalamic nucleus improves reactive inhibitory control of action impulses.
van Wouwe NC; Pallavaram S; Phibbs FT; Martinez-Ramirez D; Neimat JS; Dawant BM; D'Haese PF; Kanoff KE; van den Wildenberg WPM; Okun MS; Wylie SA
Neuropsychologia; 2017 May; 99():37-47. PubMed ID: 28237741
[TBL] [Abstract][Full Text] [Related]
4. Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease.
Eusebio A; Witjas T; Cohen J; Fluchère F; Jouve E; Régis J; Azulay JP
J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):868-74. PubMed ID: 23447648
[TBL] [Abstract][Full Text] [Related]
5. Clonidine modulates the activity of the subthalamic-supplementary motor loop: evidence from a pharmacological study combining deep brain stimulation and electroencephalography recordings in Parkinsonian patients.
Spay C; Albares M; Lio G; Thobois S; Broussolle E; Lau B; Ballanger B; Boulinguez P
J Neurochem; 2018 Aug; 146(3):333-347. PubMed ID: 29675956
[TBL] [Abstract][Full Text] [Related]
6. Functional segregation of basal ganglia pathways in Parkinson's disease.
Neumann WJ; Schroll H; de Almeida Marcelino AL; Horn A; Ewert S; Irmen F; Krause P; Schneider GH; Hamker F; Kühn AA
Brain; 2018 Sep; 141(9):2655-2669. PubMed ID: 30084974
[TBL] [Abstract][Full Text] [Related]
7. Executive control in Parkinson's disease: effects of dopaminergic medication and deep brain stimulation on anti-cue keypress performance.
Adam JJ; van Houdt H; Scholtissen B; Visser-Vandewalle V; Winogrodzka A; Duits A
Neurosci Lett; 2011 Aug; 500(2):113-7. PubMed ID: 21704125
[TBL] [Abstract][Full Text] [Related]
8. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
[TBL] [Abstract][Full Text] [Related]
9. Subthalamic nucleus stimulation, dopaminergic treatment and impulsivity in Parkinson's disease.
Fluchère F; Burle B; Vidal F; van den Wildenberg W; Witjas T; Eusebio A; Azulay JP; Hasbroucq T
Neuropsychologia; 2018 Aug; 117():167-177. PubMed ID: 29458074
[TBL] [Abstract][Full Text] [Related]
10. In Parkinson's disease STN stimulation enhances responsiveness of movement initiation speed to high reward value.
Kojovic M; Higgins A; Jahanshahi M
Neuropsychologia; 2016 Aug; 89():273-280. PubMed ID: 27371365
[TBL] [Abstract][Full Text] [Related]
11. Beta-band oscillations in the supplementary motor cortex are modulated by levodopa and associated with functional activity in the basal ganglia.
Chung JW; Burciu RG; Ofori E; Coombes SA; Christou EA; Okun MS; Hess CW; Vaillancourt DE
Neuroimage Clin; 2018; 19():559-571. PubMed ID: 29984164
[TBL] [Abstract][Full Text] [Related]
12. In Parkinson's disease on a probabilistic Go/NoGo task deep brain stimulation of the subthalamic nucleus only interferes with withholding of the most prepotent responses.
Georgiev D; Dirnberger G; Wilkinson L; Limousin P; Jahanshahi M
Exp Brain Res; 2016 Apr; 234(4):1133-43. PubMed ID: 26758720
[TBL] [Abstract][Full Text] [Related]
13. Functional and effective connectivity in subthalamic local field potential recordings of patients with Parkinson's disease.
Hohlefeld FU; Huchzermeyer C; Huebl J; Schneider GH; Nolte G; Brücke C; Schönecker T; Kühn AA; Curio G; Nikulin VV
Neuroscience; 2013 Oct; 250():320-32. PubMed ID: 23876322
[TBL] [Abstract][Full Text] [Related]
14. Deep brain stimulation improves movement amplitude but not hastening of repetitive finger movements.
Stegemöller EL; Zadikoff C; Rosenow JM; Mackinnon CD
Neurosci Lett; 2013 Sep; 552():135-9. PubMed ID: 23941889
[TBL] [Abstract][Full Text] [Related]
15. Subthalamic nucleus activity dissociates proactive and reactive inhibition in patients with Parkinson's disease.
Benis D; David O; Lachaux JP; Seigneuret E; Krack P; Fraix V; Chabardès S; Bastin J
Neuroimage; 2014 May; 91():273-81. PubMed ID: 24368260
[TBL] [Abstract][Full Text] [Related]
16. Iowa gambling task impairment in Parkinson's disease can be normalised by reduction of dopaminergic medication after subthalamic stimulation.
Castrioto A; Funkiewiez A; Debû B; Cools R; Lhommée E; Ardouin C; Fraix V; Chabardès S; Robbins TW; Pollak P; Krack P
J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):186-90. PubMed ID: 24860137
[TBL] [Abstract][Full Text] [Related]
17. Differential dopaminergic modulation of spontaneous cortico-subthalamic activity in Parkinson's disease.
Sharma A; Vidaurre D; Vesper J; Schnitzler A; Florin E
Elife; 2021 Jun; 10():. PubMed ID: 34085932
[TBL] [Abstract][Full Text] [Related]
18. Parkinson's disease, the subthalamic nucleus, inhibition, and impulsivity.
Jahanshahi M; Obeso I; Baunez C; Alegre M; Krack P
Mov Disord; 2015 Feb; 30(2):128-40. PubMed ID: 25297382
[TBL] [Abstract][Full Text] [Related]
19. Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease.
Weinberger M; Mahant N; Hutchison WD; Lozano AM; Moro E; Hodaie M; Lang AE; Dostrovsky JO
J Neurophysiol; 2006 Dec; 96(6):3248-56. PubMed ID: 17005611
[TBL] [Abstract][Full Text] [Related]
20. Subthalamic deep brain stimulation improves smooth pursuit and saccade performance in patients with Parkinson's disease.
Nilsson MH; Patel M; Rehncrona S; Magnusson M; Fransson PA
J Neuroeng Rehabil; 2013 Apr; 10():33. PubMed ID: 23551890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
